Eli Lilly and Company News Releases

Lilly and Kumquat Biosciences Announce Collaboration to Discover and Develop Novel Small Molecules that Stimulate Tumor-Specific Immune Responses

INDIANAPOLIS and SAN DIEGO , July 29, 2021 /PRNewswire/ -- Loxo Oncology at Lilly , a research and development group of Eli Lilly and Company (NYSE: LLY), and Kumquat Biosciences today announced an exclusive collaboration focused on the discovery, development and commercialization of potential
favicon
investor.lilly.com
investor.lilly.com
Create attached notes ...